Delivery Order SPE2DB20D1100-SPE2DB25FC7D8

Award Date 6/5/25
Potential Completion Date 6/6/25
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,689.25 firm fixed-price contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has a period of performance through November 13, 2024 and is not designated with a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,443.90, is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a medical product. The contract has a firm fixed price pricing type and an ultimate completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML products, with a potential value of $3,027.66 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor, and no set-aside designation was used. This...
This is a $5,131.45 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a medical product, with a completion date of July 24, 2024. The award is not designated as a set-aside contract. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, to provide the pharmaceutical product Ultane 250 ML Pen Bottle 250ML. The contract has a ceiling value of $2,778.60 and a period of performance through April 2, 2024. This award is part of a larger indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which has a potential value of up to $999,999,999.00...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,058.86 firm-fixed-price delivery order is for the supply of 4567099653 ULTANE 250 ML PEN BOTTLE 250ML medical products. The contract has a period of performance through January 31, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $1,111.44 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML pharmaceutical products and has a performance period through March 29, 2024. Amerisourcebergen Drug Corp also holds an indefinite delivery contract (IDC) from DLA valued up to $999,999,999.00 through December 31, 2025. This IDC serves as the...
This federal contract award, valued at $1,395.77, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4567467524 ! ULTANE 250 ML PEN BOTTLE 250ML, a medical product, with a period of performance through March 6, 2025. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,887.80 firm fixed-price contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, a pharmaceutical product. The contract has an ultimate completion date of April 11, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen Drug Corp with the DLA Troop Support Medical, valued at $999,999,999.00,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of ULTANE 250 ML PEN BOTTLE 250ML, a medical product, with a ceiling value of $1,732.68 and a firm fixed price pricing type. The contract has a performance period ending on May 16, 2025. This award is not set aside and is part of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB25FC7D8
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ULTANE 250 ML PEN BOTTLE 250ML, with a ceiling value of $2,406.50 and a period of performance through June 6, 2025.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This allows the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers such as the Defense Health Agency and U.S. Coast Guard.

The contract is not set-aside and was awarded through open competition. Amerisourcebergen is the prime contractor, and there is no information provided about any subcontractors.

Generated 9/4/25, 9:51 AM